Computer-aided volumetric assessment of malignant pleural mesothelioma on CT using a random walk-based method
暂无分享,去创建一个
Michael Brady | Niranjan Joshi | Fergus Gleeson | Mitchell Chen | Emma Helm | M. Brady | F. Gleeson | N. Joshi | Mitchell Chen | E. Helm
[1] S. Armato,et al. Disease volumes as a marker for patient response in malignant pleural mesothelioma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Samuel G Armato,et al. Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] Xiaorong Wang,et al. An updated review on asbestos and related diseases in China , 2012, International journal of occupational and environmental health.
[4] A. Alavi,et al. Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment , 2011, Molecular Imaging and Biology.
[5] B. Seifert,et al. Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? , 2011, European Respiratory Journal.
[6] Samuel G Armato,et al. Computerized segmentation and measurement of malignant pleural mesothelioma. , 2010, Medical physics.
[7] Binsheng Zhao,et al. Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[8] M. Metintaş,et al. Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma. , 2010, European journal of radiology.
[9] S. Armato,et al. Current state and future directions of pleural mesothelioma imaging. , 2008, Lung Cancer.
[10] S. Hutchings,et al. The burden of cancer at work: estimation as the first step to prevention , 2007, Occupational and Environmental Medicine.
[11] D. Talbot,et al. Phase II study of vinflunine in malignant pleural mesothelioma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Ullrich. Prevention of cancer through healthy workplaces. , 2007, European Journal of Cancer.
[13] Leo Grady,et al. Random Walks for Image Segmentation , 2006, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[14] T. Joshi,et al. Asbestos Ban in India , 2006, Annals of the New York Academy of Sciences.
[15] Hans-Peter Meinzer,et al. Quantification of lung tumor volume and rotation at 3D dynamic parallel MR imaging with view sharing: preliminary results. , 2006, Radiology.
[16] Samuel G Armato,et al. Modeling of mesothelioma growth demonstrates weaknesses of current response criteria. , 2006, Lung cancer.
[17] Heber MacMahon,et al. Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans. , 2005, Academic radiology.
[18] M. Byrne,et al. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] B. Escudier,et al. Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Til Aach,et al. Computer-assisted Diagnosis for Early Stage Pleural Mesothelioma , 2007, Methods of Information in Medicine.